{"success":true,"data":{"pressRelease":{"id":"21913","rtpr_id":"nBw5n1HmFa","ticker":"ATEC","exchange":"NASDAQ","all_tickers":["ATEC"],"title":"ATEC Refinances Existing Debt with Inaugural Bank Facility","author":"Business Wire","published_at":"2026-05-05T20:05:01.114Z","article_body":"ATEC Refinances Existing Debt with Inaugural Bank Facility\n\nAlphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative\nsolutions dedicated to revolutionizing the approach to spine surgery, today\nannounced it has entered into a new credit facility, including a $125 million\nrevolving credit facility and $175 million Term Loan A, led by JPMorgan Chase\nBank, N.A. and TD Securities (USA) LLC. This transaction represents ATEC’s\ninaugural syndicated bank facility and reflects the Company’s strong\noperating performance and continued progression to a more scaled and\nprofitable financial profile.\n\nThe new facility refinances the Company’s existing debt, including its prior\nterm loan and asset-based lending facilities with Braidwell LP, Pharmakon\nAdvisors LP, and MidCap Financial Trust, simplifies its capital structure,\nreduces borrowing costs, and extends maturities to 2031. At close, the\nfacility carries an interest rate of SOFR plus 275 basis points and is\nexpected to reduce interest expense by more than $6 million annually, with the\npotential to generate more than $35 million of savings over the life of the\nfacility. The new facility also includes an incremental $150 million accordion\nfeature, providing additional flexibility as the Company grows.\n\n“This transaction marks an important step in the improvement of our capital\nstructure,” said Todd Koning, Chief Financial Officer. “By lowering our\ncost of capital, extending our maturity profile, and partnering with a leading\nbank syndicate, we have strengthened our financial foundation. This new\nfacility reflects the maturation of our business and positions us with a more\nscalable and flexible financing structure as we continue to grow.”\n\n“We appreciate the support of our prior lending partners, Braidwell,\nPharmakon, and MidCap, who have been important contributors to ATEC’s\ngrowth,” added Koning.\n\nAdditional information regarding the credit facility, including a copy of the\ncredit agreement, will be included in a Current Report on Form 8-K to be filed\nby the Company with the Securities and Exchange Commission.\n\nAbout Alphatec Holdings, Inc.\n\nATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging\nS.A.S., and SafeOp Surgical, Inc., is a medical device company dedicated to\nrevolutionizing the approach to spine surgery through clinical distinction.\nATEC’s Organic Innovation Machine(TM) is focused on developing new\napproaches that integrate seamlessly with the Company’s expanding\nInformatiX(TM) platform to better inform surgery and more safely and\nreproducibly achieve the goals of spine surgery. ATEC’s vision is to be the\nStandard Bearer in Spine. For more information, visit us at www.atecspine.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DMMOtKYAkwk5TVrTpqOjNm9vZATK3oiC7Oljhay6HJ3o5lKhEhM8p_r50M1lbVEJUKgoMO7R9t8kA7CQGWkaMDA%3D%3D&esheet=54529341&newsitemid=20260505518290&lan=en-US&anchor=www.atecspine.com&index=1&md5=8317505ff3bc4629acfa85fb562916b9)\n.\n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of\nthe Private Securities Litigation Reform Act of 1995 that involve risks and\nuncertainties. Such statements are based on management's current expectations\nand are subject to a number of risks and uncertainties that could cause actual\nresults to differ materially from those described in the forward-looking\nstatements. The Company cautions investors that there can be no assurance that\nactual results will not differ materially from those projected or suggested in\nsuch forward-looking statements as a result of various factors.\nForward-looking statements include, but are not limited to: references to the\nexpected reduction in interest expense and related cost savings over the life\nof the facility; the anticipated benefits of the new credit facility,\nincluding its maturity profile, borrowing costs, and incremental accordion\nfeature; the Company's ability to utilize additional capacity under the\nfacility to support future growth; and the Company's expectations regarding\nits financial condition, capital structure, and ability to meet its financial\nobligations. Important factors that could cause actual results to differ\nsignificantly from those expressed or implied by such forward-looking\nstatements include, but are not limited to: changes in interest rates or\ncredit market conditions that affect borrowing costs; the Company's ability to\nsatisfy the terms and covenants of the new credit facility; unanticipated\nexpenses, liabilities, or other adverse events affecting cash flow or the\nCompany's ability to achieve profitability; uncertainty of additional funding;\nand the Company's ability to meet its financial obligations and achieve\nexpected financial outcomes. A further list and description of these and other\nfactors, risks and uncertainties can be found in the Company's most recent\nannual report, and any subsequent quarterly and current reports, filed with\nthe U.S. Securities and Exchange Commission. ATEC disclaims any intention or\nobligation to update or revise any forward-looking statements, whether as a\nresult of new information, future events, or otherwise, unless required by\nlaw.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260505518290/en/\n(https://www.businesswire.com/news/home/20260505518290/en/)\n\nInvestor/Media Contact: \n\nRobert Judd\n\nInvestor Relations\n\n(760) 494-6790\n\ninvestorrelations@atecspine.com (mailto:investorrelations@atecspine.com)\n\nCompany Contact: \n\nJ. Todd Koning\n\nChief Financial Officer\n\ninvestorrelations@atecspine.com (mailto:investorrelations@atecspine.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw5n1HmFa","title":"ATEC Refinances Existing Debt with Inaugural Bank Facility","author":"Business Wire","ticker":"ATEC","created":"2026-05-05T20:05:01.114Z","tickers":["ATEC"],"exchange":"NASDAQ","article_body":"ATEC Refinances Existing Debt with Inaugural Bank Facility\n\nAlphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative\nsolutions dedicated to revolutionizing the approach to spine surgery, today\nannounced it has entered into a new credit facility, including a $125 million\nrevolving credit facility and $175 million Term Loan A, led by JPMorgan Chase\nBank, N.A. and TD Securities (USA) LLC. This transaction represents ATEC’s\ninaugural syndicated bank facility and reflects the Company’s strong\noperating performance and continued progression to a more scaled and\nprofitable financial profile.\n\nThe new facility refinances the Company’s existing debt, including its prior\nterm loan and asset-based lending facilities with Braidwell LP, Pharmakon\nAdvisors LP, and MidCap Financial Trust, simplifies its capital structure,\nreduces borrowing costs, and extends maturities to 2031. At close, the\nfacility carries an interest rate of SOFR plus 275 basis points and is\nexpected to reduce interest expense by more than $6 million annually, with the\npotential to generate more than $35 million of savings over the life of the\nfacility. The new facility also includes an incremental $150 million accordion\nfeature, providing additional flexibility as the Company grows.\n\n“This transaction marks an important step in the improvement of our capital\nstructure,” said Todd Koning, Chief Financial Officer. “By lowering our\ncost of capital, extending our maturity profile, and partnering with a leading\nbank syndicate, we have strengthened our financial foundation. This new\nfacility reflects the maturation of our business and positions us with a more\nscalable and flexible financing structure as we continue to grow.”\n\n“We appreciate the support of our prior lending partners, Braidwell,\nPharmakon, and MidCap, who have been important contributors to ATEC’s\ngrowth,” added Koning.\n\nAdditional information regarding the credit facility, including a copy of the\ncredit agreement, will be included in a Current Report on Form 8-K to be filed\nby the Company with the Securities and Exchange Commission.\n\nAbout Alphatec Holdings, Inc.\n\nATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging\nS.A.S., and SafeOp Surgical, Inc., is a medical device company dedicated to\nrevolutionizing the approach to spine surgery through clinical distinction.\nATEC’s Organic Innovation Machine(TM) is focused on developing new\napproaches that integrate seamlessly with the Company’s expanding\nInformatiX(TM) platform to better inform surgery and more safely and\nreproducibly achieve the goals of spine surgery. ATEC’s vision is to be the\nStandard Bearer in Spine. For more information, visit us at www.atecspine.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DMMOtKYAkwk5TVrTpqOjNm9vZATK3oiC7Oljhay6HJ3o5lKhEhM8p_r50M1lbVEJUKgoMO7R9t8kA7CQGWkaMDA%3D%3D&esheet=54529341&newsitemid=20260505518290&lan=en-US&anchor=www.atecspine.com&index=1&md5=8317505ff3bc4629acfa85fb562916b9)\n.\n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of\nthe Private Securities Litigation Reform Act of 1995 that involve risks and\nuncertainties. Such statements are based on management's current expectations\nand are subject to a number of risks and uncertainties that could cause actual\nresults to differ materially from those described in the forward-looking\nstatements. The Company cautions investors that there can be no assurance that\nactual results will not differ materially from those projected or suggested in\nsuch forward-looking statements as a result of various factors.\nForward-looking statements include, but are not limited to: references to the\nexpected reduction in interest expense and related cost savings over the life\nof the facility; the anticipated benefits of the new credit facility,\nincluding its maturity profile, borrowing costs, and incremental accordion\nfeature; the Company's ability to utilize additional capacity under the\nfacility to support future growth; and the Company's expectations regarding\nits financial condition, capital structure, and ability to meet its financial\nobligations. Important factors that could cause actual results to differ\nsignificantly from those expressed or implied by such forward-looking\nstatements include, but are not limited to: changes in interest rates or\ncredit market conditions that affect borrowing costs; the Company's ability to\nsatisfy the terms and covenants of the new credit facility; unanticipated\nexpenses, liabilities, or other adverse events affecting cash flow or the\nCompany's ability to achieve profitability; uncertainty of additional funding;\nand the Company's ability to meet its financial obligations and achieve\nexpected financial outcomes. A further list and description of these and other\nfactors, risks and uncertainties can be found in the Company's most recent\nannual report, and any subsequent quarterly and current reports, filed with\nthe U.S. Securities and Exchange Commission. ATEC disclaims any intention or\nobligation to update or revise any forward-looking statements, whether as a\nresult of new information, future events, or otherwise, unless required by\nlaw.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260505518290/en/\n(https://www.businesswire.com/news/home/20260505518290/en/)\n\nInvestor/Media Contact: \n\nRobert Judd\n\nInvestor Relations\n\n(760) 494-6790\n\ninvestorrelations@atecspine.com (mailto:investorrelations@atecspine.com)\n\nCompany Contact: \n\nJ. Todd Koning\n\nChief Financial Officer\n\ninvestorrelations@atecspine.com (mailto:investorrelations@atecspine.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-05-05T20:05:02.450136886Z","server_sent_at_ms":1778011502450},"received_at":"2026-05-05T20:05:02.503Z","source_url":"https://www.businesswire.com/news/home/20260505518290/en/"},"analysis":{"id":"16257","press_release_id":"21913","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Alphatec Holdings secured a new $300 million syndicated credit facility led by JPMorgan and TD Securities, consisting of a $125 million revolver and $175 million term loan to replace existing debt.\n\nThe transaction extends debt maturities to 2031 and lowers the borrowing cost to SOFR plus 275 basis points, simplifying the capital structure.\n\nManagement expects the new terms to reduce annual interest expense by more than $6 million, generating over $35 million in total savings over the life of the facility.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Balance sheet de-risking with new $300M facility and lower interest costs."},"keyFigures":{"customDimensions":{"interest_rate":"SOFR plus 275 basis points","maturity_year":"2031","total_savings":"$35 million","annual_savings":"$6 million","total_facility":"$300 million","accordion_feature":"$150 million"}},"quotedText":"This transaction marks an important step in the improvement of our capital structure","namedEntities":{"people":[{"name":"Todd Koning","role":"Chief Financial Officer"},{"name":"Robert Judd","role":"Investor Relations"}],"products":["Organic Innovation Machine","InformatiX"],"companies":[{"name":"JPMorgan Chase Bank, N.A.","relationship":"lead lender"},{"name":"TD Securities (USA) LLC","relationship":"lead lender"},{"name":"Braidwell LP","relationship":"prior lender"},{"name":"Pharmakon Advisors LP","relationship":"prior lender"},{"name":"MidCap Financial Trust","relationship":"prior lender"}],"dollarAmounts":[{"amount":"$125 million","context":"revolving credit facility"},{"amount":"$175 million","context":"Term Loan A"},{"amount":"$6 million","context":"expected annual interest expense reduction"},{"amount":"$35 million","context":"total savings over the life of the facility"},{"amount":"$150 million","context":"incremental accordion feature"}]},"materialImpact":{"score":3,"reasoning":"Significant balance sheet optimization via a new $300M credit facility that extends maturities to 2031 and reduces annual interest expense by over $6M, strengthening the financial profile without being a binary business event."},"tickerRelevance":{"others":[],"primary":"ATEC"},"globalImportance":30,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid_cap","eventGravity":"debt_refinancing","sectorWeight":"health_care"}},"event_type":"other","event_type_secondary":null,"sentiment":"bullish","material_impact_score":3,"narrative":"Alphatec Holdings secured a new $300 million syndicated credit facility led by JPMorgan and TD Securities, consisting of a $125 million revolver and $175 million term loan to replace existing debt.\n\nThe transaction extends debt maturities to 2031 and lowers the borrowing cost to SOFR plus 275 basis points, simplifying the capital structure.\n\nManagement expects the new terms to reduce annual interest expense by more than $6 million, generating over $35 million in total savings over the life of the facility.","key_figures":{"customDimensions":{"interest_rate":"SOFR plus 275 basis points","maturity_year":"2031","total_savings":"$35 million","annual_savings":"$6 million","total_facility":"$300 million","accordion_feature":"$150 million"}},"named_entities":{"people":[{"name":"Todd Koning","role":"Chief Financial Officer"},{"name":"Robert Judd","role":"Investor Relations"}],"products":["Organic Innovation Machine","InformatiX"],"companies":[{"name":"JPMorgan Chase Bank, N.A.","relationship":"lead lender"},{"name":"TD Securities (USA) LLC","relationship":"lead lender"},{"name":"Braidwell LP","relationship":"prior lender"},{"name":"Pharmakon Advisors LP","relationship":"prior lender"},{"name":"MidCap Financial Trust","relationship":"prior lender"}],"dollarAmounts":[{"amount":"$125 million","context":"revolving credit facility"},{"amount":"$175 million","context":"Term Loan A"},{"amount":"$6 million","context":"expected annual interest expense reduction"},{"amount":"$35 million","context":"total savings over the life of the facility"},{"amount":"$150 million","context":"incremental accordion feature"}]},"model_name":"glm-4.7","prompt_hash":"sha256:511026a279f8af46","schema_hash":"sha256:96555d0809de301c","created_at":"2026-05-06T01:16:59.703Z","global_importance":30,"audience_relevance":25,"importance_components":{"tickerTier":"mid_cap","eventGravity":"debt_refinancing","sectorWeight":"health_care"}},"durationMs":87335,"modelName":"glm-4.7"}}